Legato Capital Management LLC Has $1.53 Million Position in Myomo, Inc. (NYSEAMERICAN:MYO)

Legato Capital Management LLC trimmed its position in shares of Myomo, Inc. (NYSEAMERICAN:MYO) by 22.8% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 237,131 shares of the company’s stock after selling 70,140 shares during the quarter. Legato Capital Management LLC’s holdings in Myomo were worth $1,527,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Barclays PLC acquired a new position in shares of Myomo in the 3rd quarter valued at about $36,000. Rosalind Advisors Inc. increased its holdings in Myomo by 13.4% in the third quarter. Rosalind Advisors Inc. now owns 3,021,391 shares of the company’s stock worth $12,116,000 after purchasing an additional 356,392 shares in the last quarter. Jane Street Group LLC acquired a new position in Myomo in the third quarter valued at approximately $65,000. GSA Capital Partners LLP boosted its holdings in shares of Myomo by 60.8% during the 3rd quarter. GSA Capital Partners LLP now owns 103,342 shares of the company’s stock worth $414,000 after buying an additional 39,085 shares in the last quarter. Finally, Vontobel Holding Ltd. acquired a new stake in shares of Myomo during the 3rd quarter worth approximately $90,000. 44.99% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

MYO has been the subject of several research analyst reports. HC Wainwright reaffirmed a “buy” rating and issued a $7.50 price target on shares of Myomo in a research note on Wednesday, November 13th. Ascendiant Capital Markets boosted their target price on Myomo from $8.50 to $9.00 and gave the company a “buy” rating in a research report on Tuesday, November 12th. Finally, Craig Hallum increased their price target on Myomo from $7.00 to $9.00 and gave the stock a “buy” rating in a report on Friday, December 13th.

Myomo Trading Up 5.4 %

NYSEAMERICAN MYO opened at $6.29 on Thursday. Myomo, Inc. has a 1 year low of $2.51 and a 1 year high of $7.17.

About Myomo

Myomo, Inc, a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient’s weak or paralyzed arm to enable and improve functional activities of daily living.